Pharmacogenetic testing to predict antipsychotic-induced weight gain: a systematic review. (Q37917782)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843067%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

0 references

1 reference

title

Pharmacogenetic testing to predict antipsychotic-induced weight gain: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843067%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843067%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Toine Egberts

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843067%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Arne J Risselada

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843067%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Hans Mulder

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843067%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

publication date

1 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843067%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843067%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843067%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843067%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

1213-1227

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843067%20AND%20SRC:MED&resulttype=core&format=json

Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol

10 February 2020

cites work

1 reference

Receptor occupancy-based analysis of the contributions of various receptors to antipsychotics-induced weight gain and diabetes mellitus

21 January 2018

1 reference

Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

21 January 2018

1 reference

Genetics of antipsychotic treatment emergent weight gain in schizophrenia

21 January 2018

1 reference

Susceptibility genes for the side effect of antipsychotics on body weight and obesity

21 January 2018

1 reference

CYP2D6 polymorphisms and atypical antipsychotic weight gain.

21 January 2018

1 reference

Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions

21 January 2018

1 reference

21 January 2018

1 reference

The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients

21 January 2018

1 reference

The relationship between P-glycoprotein (PGP) polymorphisms and response to olanzapine treatment in schizophrenia.

21 January 2018

1 reference

The association of weight gain and olanzapine plasma concentrations.

21 January 2018

1 reference

Activation of Cdk2-pRB-E2F1 cell cycle pathway by repeated electroconvulsive shock in the rat frontal cortex

21 January 2018

1 reference

Polymorphism of the adrenergic receptor alpha 2a -1291C>G genetic variation and clozapine-induced weight gain

21 January 2018

1 reference

Weight gain associated with the alpha2a-adrenergic receptor -1,291 C/G polymorphism and olanzapine treatment

21 January 2018

1 reference

Association of the alpha 2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans.

21 January 2018

1 reference

Comparative effects of oleoyl-estrone and a specific beta3-adrenergic agonist (CL316, 243) on the expression of genes involved in energy metabolism of rat white adipose tissue

21 January 2018

1 reference

BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia

21 January 2018

1 reference

Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice

21 January 2018

1 reference

Brain dopamine and obesity

21 January 2018

1 reference

Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity.

21 January 2018

1 reference

Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment

21 January 2018

1 reference

DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia

21 January 2018

1 reference

DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain

21 January 2018

1 reference

Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene

21 January 2018

1 reference

C825T polymorphism in the human G protein beta3 subunit gene is associated with long-term clozapine treatment-induced body weight change in the Chinese population

21 January 2018

1 reference

Association study of adrenergic beta3 receptor (Trp64Arg) and G-protein beta3 subunit gene (C825T) polymorphisms and weight change during clozapine treatment

21 January 2018

1 reference

G-protein beta3 Subunit Gene 825C/T Polymorphism Is Not Associated with Olanzapine-Induced Weight Gain in Korean Schizophrenic Patients.

21 January 2018

1 reference

Association of antipsychotic induced weight gain and body mass index with GNB3 gene: a meta-analysis

21 January 2018

1 reference

Genetic variant of the histamine-1 receptor (glu349asp) and body weight change during clozapine treatment

21 January 2018

1 reference

Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors

21 January 2018

1 reference

Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism

21 January 2018

1 reference

Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain

21 January 2018

1 reference

Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine

21 January 2018

1 reference

Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis

21 January 2018

1 reference

Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism

21 January 2018

1 reference

-759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment

21 January 2018

1 reference

Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene.

21 January 2018

1 reference

Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.

21 January 2018

1 reference

Risperidone-induced weight gain in referred children with autism spectrum disorders is associated with a common polymorphism in the 5-hydroxytryptamine 2C receptor gene

21 January 2018

1 reference

-759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

21 January 2018

1 reference

Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals

21 January 2018

1 reference

Association between a TGFbeta1 promoter polymorphism and the phenotype of aspirin-intolerant chronic urticaria in a Korean population

21 January 2018

1 reference

Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone

21 January 2018

1 reference

759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain

21 January 2018

1 reference

HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis

21 January 2018

1 reference

Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis

21 January 2018

1 reference

Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis

21 January 2018

1 reference

Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain.

21 January 2018

1 reference

Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment

21 January 2018

1 reference

Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population

21 January 2018

1 reference

Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents

21 January 2018

1 reference

Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia

21 January 2018

1 reference

Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from north India: role of metabolic pathway genes

21 January 2018

1 reference

The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia

21 January 2018

1 reference

SNAP-25 gene polymorphisms and weight gain in schizophrenic patients

21 January 2018

1 reference

Stress and affective disorders: animal models elucidating the molecular basis of neuroendocrine-behavior interactions

21 January 2018

1 reference

Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients

21 January 2018

1 reference

Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?

21 January 2018

1 reference

Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients

21 January 2018

1 reference

The association of olanzapine-induced weight gain with peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism in patients with schizophrenia.

21 January 2018

1 reference

Genetic association between TNF-alpha -308 G>A polymorphism and longitudinal weight change during clozapine treatment

21 January 2018

1 reference

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia

21 January 2018

1 reference

Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain

21 January 2018

1 reference

MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study

21 January 2018

1 reference

STrengthening the REporting of Genetic Association Studies (STREGA): An Extension of the STROBE Statement

21 January 2018

1 reference

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

21 January 2018

1 reference

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

21 January 2018

1 reference

Weight gain: side effect of atypical neuroleptics?

21 January 2018

1 reference

Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients.

21 January 2018

1 reference

Signals that regulate food intake and energy homeostasis.

21 January 2018

1 reference

Clinical endocrinology and metabolism. Regulation of energy homeostasis by peripheral signals

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.11.67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21843067%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference